HIV-1 induces telomerase activity in monocyte-derived macrophages, possibly safeguarding one of its reservoirs
; Wieser, Matthias ; Ojeda, Diego ; Bönisch, Maximilian ; Kühnel, Harald ; Bolcic, Federico Martin
; Quendler, Heribert ; Grillari, Johannes ; Grillari Voglauer, Regina ; Quarleri, Jorge Fabian 
Otros responsables
Fecha
10/2012
Editorial
American Society for Microbiology
Revista
Journal of Virology
Título del libro
Nombre del evento
Fecha del evento
Institución organizadora
ISSN
0022-538X
eISSN
ISBN
Idioma
Inglés
Tipo del evento
Clasificación temática
Palabras clave
Resumen
Monocyte-derived macrophages (MDM) are widely distributed in all tissues and organs, including the central nervous system, where they represent the main part of HIV-infected cells. In contrast to activated CD4+ T lymphocytes, MDMare resistant to cytopathic effects and survive HIV infection for a long period of time. The molecular mechanisms of how HIV is able to persist in macrophages are not fully elucidated yet. In this context, we have studied the effect of in vitro HIV-1 infection on telomerase activity (TA), telomere length, and DNA damage. Infection resulted in a significant induction of TA. This increase was directly proportional to the efficacy of HIV infection and was found in both nuclear and cytoplasmic extracts, while neither UV lightinactivated HIV nor exogenous addition of the viral protein Tat or gp120 affected TA. Furthermore, TA was not modified during monocyte-macrophage differentiation, MDMactivation, or infection with vaccinia virus. HIV infection did not affect telomere length. However, HIV-infectedMDMshowed less DNA damage after oxidative stress than noninfected MDM, and this resistance was also increased by overexpressing telomerase alone. Taken together, our results suggest that HIV induces TA inMDMand that this induction might contribute to cellular protection against oxidative stress, which could be considered a viral strategy to make macrophages better suited as longer-lived, more resistant viral reservoirs. In the light of the clinical development of telomerase inhibitors as anticancer therapeutics, inhibition of TA in HIV-infected macrophages might also represent a novel therapeutic target against viral reservoirs.
Colecciones
Aprobación
Revisión
Complementado por
Referenciado por
Licencia Creative Commons
Excepto donde se indique lo contrario, la licencia de este ítem se describe como by
